Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice

Gene therapy offers the potential to cure hemophilia A (HA). We have shown that hematopoietic stem cell (HSC)–based platelet-specific factor VIII (FVIII) (2bF8) gene therapy can produce therapeutic protein and induce antigen-specific immune tolerance in HA mice, even in the presence of inhibitory an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Gao, Chunyan, Schroeder, Jocelyn A., Xue, Feng, Jing, Weiqing, Cai, Yuanhua, Scheck, Amelia, Subramaniam, Saravanan, Rao, Sridhar, Weiler, Hartmut, Czechowicz, Agnieszka, Shi, Qizhen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Gene Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6759737/
https://ncbi.nlm.nih.gov/pubmed/31515232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000516
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados